Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA newer revision tag (v3.6.3) was added to the history list, replacing the previous v3.6.2 label, indicating an update to the study record's versioning.SummaryDifference0.1%

- Check22 days agoChange DetectedA new Revision: v3.6.2 tag appears on the page, replacing the previous Revision: v3.6.0. This reflects a system update without altering study data or history content.SummaryDifference0.1%

- Check37 days agoChange DetectedRecruitment status updated to no longer looking for participants. The record revision was updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.3%

- Check44 days agoChange DetectedThe record history gains an additional revision entry (v3.5.5) indicating a minor update to the history log, replacing the prior v3.5.4.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.4 was added to the Record History, replacing v3.5.3. This marks a new version of the study record.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page’s interface/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software release rather than a change to the underlying clinical trial record history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.